Market Tracker

08/21 7:42am ET

Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

2.12
Delayed Data
As of Aug 18
 +0.11 / +5.47%
Today’s Change
1.20
Today|||52-Week Range
8.22
+36.77%
Year-to-Date
No recent news for Arrowhead Pharmaceuticals Inc.

Today’s Trading

Previous close2.01
Today’s open2.03
Day’s range2.00 - 2.26
Volume1,837,615
Average volume (3 months)822,421
Market cap$158.5M
Dividend yield--
Data as of 3:59pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+16.25%
Earnings growth (this year)+68.66%
Earnings growth (next 5 years)--
Revenue growth (last year)-58.55%
P/E ratioNM
Price/Sales2,834.05
Price/Book1.55

Competitors

 Today’s
change
Today’s
% change
AVXLAnavex Life Sciences...+0.14+3.69%
CASCCascadian Therapeuti...-0.09-2.47%
BCLIBrainstorm Cell Ther...+0.02+0.48%
CDXSCodexis Inc+0.15+2.83%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateDecember 20, 2017
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$158.3K
Annual profit (last year)-$81.7M
Net profit margin-51,614.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Christopher Richard Anzalone
Chief Operating Officer
Bruce D. Given
Corporate headquarters
Pasadena, California

Forecasts